Celltrion Covid
Scope
Date
~
-
Bio & Pharma
Celltrion to expand biosimilar portfolio to 11 by 2025
South Korea's biopharmaceutical company Celltrion Inc. announced on Tuesday that it plans to beef up its portfolio by applying for regulatory approv...
Jun 13, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion to develop Humira biosimilar oral medication with US firm
South Korea's biopharmaceutical company Celltrion Inc. announced on Monday that it has signed a contract with the US biotech firm Rani Therapeutics ...
Jun 05, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s Remsima SC praised in Europe as preferred biosimilar
MILAN – South Korea's biopharmaceutical company Celltrion Inc. is known in Europe for its biosimilar products such as autoimmune disease treat...
Jun 02, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion unveils phase 1 clinical data of Actemra biosimilar in Europe
South Korean biosimilar giant Celltrion Inc. revealed on Wednesday the highly anticipated clinical phase 1 data for its Actemra biosimilar, CT-P47, ...
May 31, 2023 (Gmt+09:00)
-
Economy
S.Korean overseas card spending near pre-COVID-19 levels
South Korean residents’ overseas card use jumped in the first quarter to nearly recover levesl before the outbreak of COVID-19 on rising inter...
May 31, 2023 (Gmt+09:00)
-
Bio & Pharma
BIO USA 2023 to draw S.Korean biotech leaders, startups
More than 500 South Korean companies from top business groups to AI-based biotech startups are slated to attend the Bio International Convention 202...
May 30, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience’s COVID-19 vaccine gets approval in UK
SK Bioscience Co., the drug-making unit of South Korea’s SK Group, said on Monday that its domestic COVID-19 vaccine, SKYCovione, has rec...
May 30, 2023 (Gmt+09:00)
-
Earnings
S.Korean karaoke machine leader TJ Media enjoys post-pandemic boom
South Koreans’ love for singing is no secret, and with the lifting of social-distancing rules in the post-pandemic era their suppressed desire...
May 26, 2023 (Gmt+09:00)
-
Travel & Leisure
S.Korean's interest in Japan travel surpasses pre-No Japan levels
A survey result indicates an increased interest in travel to Japan compared to pre-No Japan boycott levels, while interest in travel to China has pl...
May 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion gets FDA approval for Humira biosimilar CT-P17
South Korean biopharmaceutical company Celltrion Inc. announced on Wednesday that it has obtained product approval from the US Food and Drug Adminis...
May 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Cellid applies for Phase 3 clinical trials in S.Korea for COVID-19 vaccine
South Korean bio-venture Cellid Co. announced on Tuesday that it has applied for the clinical Phase 3 trial of the COVID-19 Omicron variant-specific...
May 23, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare launches Remsima SC in Brazil
South Korean biopharmaceutical company Celltrion Healthcare Co. revealed on Monday its introduction of Remsima SC, a treatment for autoimmune diseas...
May 22, 2023 (Gmt+09:00)
-
Retail
S.Korea’s Dongdaemun fashion district shows revival post-COVID-19
Doosan Tower, the most visible shopping mall in the Dongdaemun fashion market, is finally making a comeback. The number of foreign visitors seeking ...
May 11, 2023 (Gmt+09:00)
-
COVID-19
Korea to lift most COVID-19 rules with lower crisis level
South Korean President Yoon Suk Yeol on Thursday declared an end to most COVID-19 restrictions including mandatory quarantine for patients of the pa...
May 11, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Celltrion drops bid to acquire Baxter’s biopharm unit
Celltrion Inc. announced on Tuesday it has decided not to pursue the acquisition of the biopharmaceutical unit of U.S. medical device maker Baxter I...
May 09, 2023 (Gmt+09:00)
-
Bio & Pharma
FDA suspends COVID-19 diagnostic kit of S.Korea’s SD Biosensor
The US Food and Drug Administration (FDA) has recommended that consumers discard select models of Pilot COVID-19 self-diagnostic test kits sold on t...
May 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for Phase 3 clinical trials in Europe for biosimilar
South Korea’s Celltrion Inc. is speeding up global clinical trials of its biosimilar of the multiple sclerosis (MS) treatment Ocrevus (active ...
May 03, 2023 (Gmt+09:00)
-
Food & Beverage
S.Korean foodservice companies’ entering to US expanded in 2022
South Korean foodservice companies expanded their presence in the US and Japan, while facing declining prospects in China due to COVID-19 restrictio...
Apr 25, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare enters top 10 in hospital prescriptions in Turkey
South Korean biopharmaceutical company Celltrion Healthcare Co. on Thursday said it ranked in the top 10 out of 400 companies last year on the Turki...
Apr 21, 2023 (Gmt+09:00)
-
Private equity
MBK Partners co-founder tops 50 richest S.Koreans: Forbes
Michael ByungJu Kim, co-founder and partner at private equity firm MBK Partners, has topped the ranking of the 50 richest South Koreans by net worth...
Apr 18, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Celltrion Healthcare launches Vegzelma in US
South Korea's Celltrion Healthcare Co. on Monday said it launched on the US market Vegzelma, a biosimilar of Bevacizumab, a medication for colorecta...
Apr 17, 2023 (Gmt+09:00)
-
Tech, Media & Telecom
Number of Netflix users in S. Korea drops 30% in a year
The number of Netflix users in South Korea has decreased by more than 30% in the past year since the recovery from COVID-19. According to Byun Jae-...
Apr 11, 2023 (Gmt+09:00)
-
Airlines
S.Korea seeks to restore volume of int'l flights to pre-COVID-19 levels
Resuming flights from Incheon International Airport to and from Prague, Czech Republic, and Zurich, Switzerland, to expand its air traffic, South Ko...
Apr 03, 2023 (Gmt+09:00)
-
Retail
Top Korean food delivery app posts record profits
Woowa Brothers Corp., the operator of South Korea’s top food delivery app, posted a record profit in 2022, which also marked its first profit ...
Mar 31, 2023 (Gmt+09:00)
-
COVID-19
S.Korea to cut COVID-19 quarantine from seven days to five in May
South Korea’s mandatory quarantine for confirmed COVID-19 patients from May will be cut from seven days to five, as the country is expected to...
Mar 30, 2023 (Gmt+09:00)
-
Bio & Pharma
Biosimilar giant Celltrion to transform into drug developer
South Korean biosimilar giant Celltrion Group aims to transform into a drug developer by generating 40% of sales from new medicines by 2030 as it is...
Mar 29, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion founder returns to management with M&A pledge
South Korean biosimilar giant Celltrion Group’s founder Seo Jung-jin has returned to management two years after his departure, pledging to mer...
Mar 28, 2023 (Gmt+09:00)
-
Retail
S.Korea's E-Mart24 provides VAT refund service for foreign visitors
E-Mart24 Inc., the convenience store chain unit of Shinsegae Inc. Group, announced on Tuesday that it will resume the value-added tax (VAT) refund s...
Mar 28, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Celltrion eyes Baxter's arm as it gears up for M&As
Celltrion Inc., South Korea’s largest biosimilar maker, said on Tuesday it has studied a possible acquisition of the biopharma solutions unit ...
Mar 21, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion, Genuv sign agreement for antibody joint R&D
South Korean biopharmaceutical firm Celltrion Inc. announced on Tuesday a joint research and development agreement with Genuv, Inc., a domestic drug...
Mar 14, 2023 (Gmt+09:00)